1-3 of 3
Giuseppe Saglio, PhD
Close
Sort by
Journal Articles

Prognostic Value of BCR-ABL1 Transcript Type in Chronic Myeloid Leukemia Patients Treated Frontline with Nilotinib

Fausto Castagnetti, MD, Gabriele Gugliotta, MD PhD, Massimo Breccia, MD, Fabio Stagno, MD PhD, Mariella D'Adda, MD, Luciano Levato, MD, Angelo Michele Carella, Bruno Martino, MD, Mario Tiribelli, MD, Carmen Fava, MD, Gianni Binotto, MD, Paolo Avanzini, MD, Monica Bocchia, Micaela Bergamaschi, MD, Antonella Russo Rossi, MD, Francesco Cavazzini, Elisabetta Abruzzese, MD, Simona Soverini, Giuliana Alimena, Michele Cavo, MD, Giovanni Martinelli, MD Prof., Fabrizio Pane, MD, Giuseppe Saglio, PhD, Michele Baccarani, Gianantonio Rosti, MD
Journal: Blood
Blood (2016) 128 (22): 3070.
https://doi.org/10.1182/blood.V128.22.3070.3070
Published: 2016
Journal Articles

The AKT/mTOR/P70S6K/4EB-P1 Signaling Pathway Is Activated in a Subset of Multiple Myeloma Patients and Correlates with High Serum Levels of Beta2-Microglobulin

Tommasina Guglielmelli, MD, Susanna Cappia, MD, Emilia Giugliano, PhD, Roberta Merlini, MD, Elisa Bacillo, MD, Francesca Gay, MD, Paola Berchialla, PhD, Dario Gregori, PhD, Mauro Papotti, PhD, Antonio Palumbo, MD, Giuseppe Saglio, PhD
Journal: Blood
Blood (2008) 112 (11): 2716.
https://doi.org/10.1182/blood.V112.11.2716.2716
Published: 2008
Journal Articles

Activation of the mTOR Signaling Pathway in Multiple Myeloma Patients and Its Prognostic Significance.

Tommasina Guglielmelli, MD, Susanna Cappia, MD, Emilia Giugliano, MD, Roberta Merlini, MD, Stefano Mussino, MD, Elena Bacillo, MD, Enrico Bracco, PhD, Maurizio Papotti, PhD, Giuseppe Saglio, PhD
Journal: Blood
Blood (2007) 110 (11): 1493.
https://doi.org/10.1182/blood.V110.11.1493.1493
Published: 2007